Chronic itch or pruritus is the most common symptom in dermatology yet less than 50% of patients will respond to treatment. Much like chronic pain, pruritus is detrimental to patient well-being. New research led by Professor Martin Steinhoff has identified a potential target to treat itch in patients who do not respond to anti-histamine drugs.
Dr Wenxin Wang will develop artificial skin to promote wound healing in patients through new funding received under the SFI Investigator programme.
Dr Wenxin Wang and his team publish details of a ground-breaking synthesis process for polymers that will allow new compounds for gene therapy applications to be easily made.